Maaisha Osman
@maaisha.bsky.social
Health policy journalist • cinema on the side
Signal: maaisha.07
Signal: maaisha.07
6. @maybarduk.bsky.social said Harvard holds “very valuable” patents, making them a ripe target for a political feud that could result in a “big cash payout” or continued harassment.
Link for subscribers: insidehealthpolicy.com/inside-drug-...
Link for subscribers: insidehealthpolicy.com/inside-drug-...
Watchdogs: Harvard Patent Probe Is Politically Motivated Amid Wider Disclosure Lapses | InsideHealthPolicy.com
The U.S. Commerce Department has launched an aggressive review of Harvard University’s management of patents tied to federally funded research, accusing the Ivy League institution of violating disclos...
insidehealthpolicy.com
August 12, 2025 at 9:56 PM
6. @maybarduk.bsky.social said Harvard holds “very valuable” patents, making them a ripe target for a political feud that could result in a “big cash payout” or continued harassment.
Link for subscribers: insidehealthpolicy.com/inside-drug-...
Link for subscribers: insidehealthpolicy.com/inside-drug-...
5. Even if a case had merit, @jamielove.bsky.social said, using it selectively means Trump is “acting like a mafia figure.”
August 12, 2025 at 9:56 PM
5. Even if a case had merit, @jamielove.bsky.social said, using it selectively means Trump is “acting like a mafia figure.”
4. @jamielove.bsky.social said Harvard is not the only institution to have failed to disclose government funding tied to its patents. But he argued the Commerce Department’s action was less about fixing systemic compliance issues and more about targeting a political adversary.
James Packard Love (@jamielove.bsky.social)
I work at https://keionline.org/jamie. Best known for work on intellectual property rights, and find most interesting ways to reform incentives and also build out global norms and mechanisms to incr...
jamielove.bsky.social
August 12, 2025 at 9:56 PM
4. @jamielove.bsky.social said Harvard is not the only institution to have failed to disclose government funding tied to its patents. But he argued the Commerce Department’s action was less about fixing systemic compliance issues and more about targeting a political adversary.
3. In 2019, the watchdog group Knowledge Ecology International (KEI) urged NIH to investigate whether Harvard’s Dana-Farber Cancer Institute failed to disclose federal funding on six lucrative cancer immunotherapy patents co-assigned to the institute.
August 12, 2025 at 9:56 PM
3. In 2019, the watchdog group Knowledge Ecology International (KEI) urged NIH to investigate whether Harvard’s Dana-Farber Cancer Institute failed to disclose federal funding on six lucrative cancer immunotherapy patents co-assigned to the institute.
2. While investigations have shown that many top universities have skirted disclosure laws, watchdog groups say that this probe appears less about enforcing the law uniformly & more about targeting Harvard in a political battle over control of lucrative taxpayer-backed inventions.
August 12, 2025 at 9:56 PM
2. While investigations have shown that many top universities have skirted disclosure laws, watchdog groups say that this probe appears less about enforcing the law uniformly & more about targeting Harvard in a political battle over control of lucrative taxpayer-backed inventions.
@jamielove.bsky.social said Harvard is not the only institution to have failed to disclose government funding tied to its patents. But he argued the Commerce Department’s action was less about fixing systemic compliance issues and more about targeting a political adversary.
August 12, 2025 at 9:53 PM
@jamielove.bsky.social said Harvard is not the only institution to have failed to disclose government funding tied to its patents. But he argued the Commerce Department’s action was less about fixing systemic compliance issues and more about targeting a political adversary.
3. In 2019, the watchdog group Knowledge Ecology International (KEI) urged NIH to investigate whether Harvard’s Dana-Farber Cancer Institute failed to disclose federal funding on six lucrative cancer immunotherapy patents co-assigned to the institute.
August 12, 2025 at 9:53 PM
3. In 2019, the watchdog group Knowledge Ecology International (KEI) urged NIH to investigate whether Harvard’s Dana-Farber Cancer Institute failed to disclose federal funding on six lucrative cancer immunotherapy patents co-assigned to the institute.
2. While investigations have shown that many top universities have skirted disclosure laws, watchdog groups say that this probe appears less about enforcing the law uniformly & more about targeting Harvard in a political battle over control of lucrative taxpayer-backed inventions.
August 12, 2025 at 9:53 PM
2. While investigations have shown that many top universities have skirted disclosure laws, watchdog groups say that this probe appears less about enforcing the law uniformly & more about targeting Harvard in a political battle over control of lucrative taxpayer-backed inventions.
Some generic drugs are exempted from the deal.
Link for subscribers: insidehealthpolicy.com/inside-drug-...
Link for subscribers: insidehealthpolicy.com/inside-drug-...
insidehealthpolicy.com
July 28, 2025 at 10:16 PM
Some generic drugs are exempted from the deal.
Link for subscribers: insidehealthpolicy.com/inside-drug-...
Link for subscribers: insidehealthpolicy.com/inside-drug-...
Full details on the meeting: insidehealthpolicy.com/share/149694
| InsideHealthPolicy.com
insidehealthpolicy.com
July 24, 2025 at 12:00 PM
Full details on the meeting: insidehealthpolicy.com/share/149694
Link for full story: insidehealthpolicy.com/share/149220
| InsideHealthPolicy.com
insidehealthpolicy.com
June 27, 2025 at 8:29 PM
Link for full story: insidehealthpolicy.com/share/149220